Merrimack Pharmaceuticals (NASDAQ: MACK) has notified NASDAQ of its intention to delist its securities, pending stockholder approval of the Plan of Dissolution at the scheduled Special Meeting on May 10, 2024. The plan entails issuing an initial liquidating cash dividend…
Heidelberg Engineering invites ARVO delegates to explore its cutting-edge imaging technology across various applications, spanning from fundamental vision research to clinical trials and guided therapy. These advancements, rooted in diagnostic imaging excellence, aim to enhance patient care by revealing deeper…
Emtora Biosciences, Inc., a San Antonio-based biotech firm, has announced the acceptance of an abstract for oral presentation at the upcoming Digestive Disease Week Annual Meeting. This prestigious event gathers professionals in gastroenterology, hepatology, endoscopy, and gastrointestinal surgery worldwide. Dr.…
Locate Bio, an innovative orthobiologics firm, has concluded an oversubscribed £9.2 million funding round with support from new and existing investors, including Mercia Ventures and BGF. The funding will facilitate a clinical study for LDGraft, a bone graft substitute designed…
MiLaboratories, renowned for RNA immune technologies, and Miltenyi Biotec, a global biotechnology leader, join forces in a groundbreaking partnership set to transform next-generation therapies. This collaboration merges MiLaboratories’ innovative RNA kit technology for immune sequencing with Miltenyi Biotec’s extensive production…
The top-line findings from the DESTINY-Breast06 phase 3 trial reveal a significant advancement with ENHERTU® (trastuzumab deruxtecan). Compared to standard chemotherapy, ENHERTU demonstrated both statistically and clinically significant enhancements in progression-free survival (PFS) for patients with HR positive, HER2 low…
StatLab Medical Products, a prominent developer and producer of medical diagnostic supplies and equipment, has revealed its acquisition of Scientific Device Laboratory (SDL). Based in Chicago, SDL specializes in printed diagnostic slides, along with various consumables and kits for anatomic…
Align Technology, Inc. (Nasdaq: ALGN), a leading medical device company renowned for its Invisalign® clear aligners and iTero™ scanners, has announced intentions to conduct a $150 million open market repurchase. This initiative is part of the company’s $1.0 billion stock…
LENSRXLAB, known for diabetic, safety, and dress eyewear, is introducing its new Supplemental Vision Benefits Platform for Diabetics, poised to transform vision care. Founded by a Military Submarine Force Veteran and Optometrist, this platform provides a comprehensive prescription diabetic eyewear…
Multiply Labs and GenScript Biotech Corporation have announced a strategic partnership to automate the cell isolation phase of cell therapy manufacturing, simplifying the process. Multiply Labs and GenScript Biotech Corporation have embarked on a collaborative effort to automate the cell…
“AndHealth Teams Up with PrimaryOne Health to Expand Specialty Care Access and Address Health Inequities” AndHealth and PrimaryOne Health have joined forces to offer in-house specialty care to their communities. PrimaryOne Health, known as the oldest and largest Community Health…
FeelBetter Collaborates with Brigham and Women’s Hospital to Study Impact of Precision Population Health Platform on Polypharmacy Management In February 2024, FeelBetter initiated a joint study with Brigham and Women’s Hospital, focusing on patients at the Phyllis Jen Center for…